TLRY vs. ACB, CGC, CRON, OGI, SNDL, CYTK, MRUS, RNA, GRFS, and ABVX
Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), Cytokinetics (CYTK), Merus (MRUS), Avidity Biosciences (RNA), Grifols (GRFS), and Abivax (ABVX). These companies are all part of the "pharmaceutical products" industry.
Tilray Brands vs. Its Competitors
Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.
Aurora Cannabis has higher revenue and earnings than Tilray Brands. Aurora Cannabis is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Tilray Brands has a consensus price target of $2.00, suggesting a potential upside of 19.05%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.
Aurora Cannabis has a net margin of -5.66% compared to Tilray Brands' net margin of -258.54%. Aurora Cannabis' return on equity of -1.49% beat Tilray Brands' return on equity.
In the previous week, Tilray Brands had 30 more articles in the media than Aurora Cannabis. MarketBeat recorded 33 mentions for Tilray Brands and 3 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.93 beat Tilray Brands' score of 0.73 indicating that Aurora Cannabis is being referred to more favorably in the media.
Aurora Cannabis has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500.
47.6% of Aurora Cannabis shares are owned by institutional investors. Comparatively, 9.4% of Tilray Brands shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Comparatively, 0.8% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Aurora Cannabis beats Tilray Brands on 10 of the 17 factors compared between the two stocks.
Get Tilray Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tilray Brands Competitors List
Related Companies and Tools
This page (NASDAQ:TLRY) was last updated on 10/16/2025 by MarketBeat.com Staff
